A cardiovascular harm-reduction guide for enhanced athletes covering symptoms, blood pressure, bloodwork, ECG, Holter monitoring, echocardiograms and when further cardiac assessment may be warranted.
20 min read
Get The PDFPerformance-enhancing compounds can affect cardiovascular health through several different pathways — including blood pressure, heart rate and rhythm, cholesterol and ApoB, haematocrit, cardiac structure and overall cardiovascular workload.
What's Inside
Written for enhanced athletes and serious lifters who want a structured approach to cardiovascular monitoring and harm reduction. It is particularly useful for understanding which symptoms matter, which basic health markers should be monitored and when ECG, rhythm monitoring, echocardiography or more advanced assessment may be appropriate. It is educational and does not replace medical evaluation.
The Enhanced Heart Check is a symptom-first cardiovascular assessment framework designed to help enhanced athletes understand what to monitor, which tests answer which questions and when medical assessment should take priority over self-testing.
The Enhanced Heart Check is a cardiovascular triage and testing framework.
Instead of recommending a large panel of tests for everyone, it starts with symptoms, exposure history and basic cardiovascular measurements before progressing to more specialised testing when there is a reason to do so.
Different exposures can place stress on different cardiovascular systems.
The guide examines six major pathways: heart rate and sympathetic drive, blood pressure, lipids and atherosclerotic risk, blood and haematocrit, structural changes to the heart muscle and the heart's electrical system.
Androgens, stimulants, beta-2 agonists and thyroid hormones can affect these pathways differently.
The guide separates symptoms into emergency, medical-assessment and baseline-monitoring categories.
Chest pain or pressure, severe breathlessness, fainting, collapse and certain combinations of palpitations with other serious symptoms warrant urgent medical assessment rather than waiting for routine bloodwork.
Recurring palpitations, unexplained reductions in exercise tolerance, persistent changes in resting heart rate, irregular pulse and repeatedly elevated blood pressure may also warrant medical evaluation.
Some of the highest-value information requires very little technology.
The guide prioritises properly measured blood pressure, resting heart rate, pulse regularity, exercise tolerance, family history and exposure history.
Changes against your own established baseline can often be more informative than looking at a single isolated measurement.
The guide discusses full blood count, fasting lipid profile, ApoB, HbA1c, kidney function, electrolytes and thyroid testing when relevant.
These markers help assess cardiovascular risk factors such as elevated haematocrit, adverse lipid changes, metabolic health, kidney function and potential electrolyte abnormalities.
A resting 12-lead ECG provides a snapshot of the heart's electrical activity.
It can identify heart rate and rhythm during the recording, atrial fibrillation or flutter when present, conduction abnormalities and certain repolarisation changes.
However, a normal resting ECG does not rule out every cardiovascular problem or an intermittent arrhythmia that was not occurring during the recording.
The important principle is to capture the heart rhythm while symptoms are actually happening.
If palpitations are intermittent, longer ambulatory monitoring such as a Holter or patch monitor may be more useful than repeatedly taking short resting ECGs.
The appropriate monitoring duration depends on how frequently symptoms occur.
An echocardiogram evaluates cardiac structure and function, including chamber dimensions, ventricular wall thickness, systolic and diastolic function, valves and other structural features.
The guide emphasises that an echo is most useful when symptoms, examination findings, blood pressure, ECG findings, family history or another clinical concern creates a structural question that needs answering.
No.
Troponin is primarily a marker of heart muscle injury and requires clinical context. It is not presented in this guide as a general wellness score or routine monthly screening marker.
When concerning acute chest symptoms occur, troponin belongs within proper medical assessment alongside ECG and clinical evaluation.
No. Advanced testing should answer a specific clinical question.
The guide covers ambulatory blood pressure monitoring, Holter monitoring, exercise testing, echocardiography, coronary calcium scoring, coronary CT angiography, cardiac MRI, BNP/NT-proBNP and troponin.
Which test is appropriate depends on symptoms, cardiovascular risk, exposure history and findings from simpler assessments.
Start with what is actually happening.
Know your baseline, monitor meaningful changes, use basic high-value measurements first and match further testing to the specific problem being investigated.
Advanced testing should not replace symptom assessment, blood pressure monitoring, basic laboratory work or qualified medical evaluation.
The guide prioritises blood pressure, resting heart rate, pulse regularity, exercise tolerance, lipid profile and ApoB, full blood count including haematocrit, metabolic markers, kidney function, electrolytes and relevant thyroid testing.
Not automatically. The guide recommends matching echocardiography to a structural question raised by symptoms, examination findings, hypertension, ECG abnormalities, family history or other relevant clinical findings.
No. The guide explains that troponin is a marker of heart muscle injury rather than a general cardiovascular wellness marker and should be interpreted in the appropriate clinical context.
A resting ECG records the heart's electrical activity for a short period, while ambulatory monitoring records for longer and can help capture intermittent rhythm disturbances. The monitoring duration should be matched to how frequently symptoms occur.
This guide is for educational purposes only and is not medical advice.
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.
